Search for: "In re Cipro Cases" Results 61 - 78 of 78
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Jun 2010, 6:30 pm by Gene Quinn
When asked for comment he offered that he thinks “the Cipro case may well be the turning point in legal treatment of reverse settlements. [read post]
31 Aug 2009, 7:25 pm
(Class 46)   Germany German Federal Patent Court affirms DMPA’s assessment of no likelihood of confusion in ‘Das Schokoladenmädchen’ (chocolate girl) case (Class 46) Typical licence fees in German (IP finance)   India The Mashelkar Committee Report on incremental patents: A 3D perspective (Spicy IP) The ‘Correa’ controversy (Spicy IP) (Spicy IP) (Spicy IP) Kurian plans hiring spree for Indian Patent and Trademark… [read post]
10 Sep 2010, 1:05 am
The active members of the circuit issued a brief ruling Tuesday saying they had voted to deny rehearing en banc a case in which a three-judge panel in April affirmed summary judgment for Bayer AG on a Sherman Act challenge concerning a so-called "pay-for-delay" agreement involving the antibiotic drug Cipro. [read post]
30 Nov 2009, 12:00 am
Jones(IP finance)   Poland New Chairman of the Polish Chamber of Patent Attorneys (Class 46)   South Africa Department of Trade & Industry proceeds with plans to convert CIPRO into self-standing commission (Afro-IP) CIPRO Risk Manager suspended on charge of ‘breach of confidentiality’ (Afro-IP)   Spain Supreme Court on slogan trade marks: no need of a special treatment (if anyone still doubted) (Class 46) Rock band La Quinta Estación name… [read post]
7 Sep 2009, 12:53 am
Guidelines re registered designs – Circular M N 74 (The IP Factor)   Italy Door opens for design owners in Italy: Lualdi v Dorica (Class 99)   Korea Korean six-month safe harbor for patents (Patent Baristas) Korean government proposing to spend USD 400 million on protecting IP (IP finance) Copyright against censorship: Authors of ‘A Modern and Contemporary History of Korea’ successfully sue publisher for copyright infringement for publishing… [read post]
1 Jun 2009, 9:11 pm
  Bob Wachter, at Wachter's World, delves deeper into the problem, and says:I'm proud to say that over the past five years, my hospital (UCSF Medical Center) has taken Leape's challenge to heart, withdrawing clinical privileges (and filing accompanying NPDB reports) in several cases for behavior that, I'm quite confident, would have been tolerated a decade ago. [read post]
14 Nov 2008, 10:46 pm
In other words, you’re going to, at the least, throw a monkey wrench into their year-end tax planning. [read post]
12 Feb 2024, 6:00 am by Daniel J. Gilman
And while we’re at it, comments to NIST from intellectual-property experts (here and here) and additional comments from Alden (here). [read post]
20 Jul 2009, 2:00 am
: TTAB says STEAM N’ MASH merely descriptive of process potatoes: In re ProMark Brands Inc (not precedential) (TTABlog) WYHA? [read post]
1 Jul 2015, 8:48 pm by Bill Marler
Today, the Court in Georgia Federal Court in the criminal case against Stewart Parnell, et al., allowed the defense to question whether PCA and Stewart Parnell was responsible for the death of nine. [read post]
14 Sep 2009, 5:51 am
Castro v Cartwright (TTABlog) TTAB reverses 2(e)(2) refusal of PROFUMO DE FIRENZE for perfume, finding double entendre: In re Atelier Profumo Artistico Firenze SrL (not precedential) (TTABlog) TTAB affirms failure-to-function refusal of STRENGTH IN DATA for brochures: In re ImClone Systems Incorporated (not precedential) (TTABlog) TTAB affirms 2(d) r [read post]
29 Mar 2010, 6:58 am
– Associated Press and fair use (Spicy IP) Copyright office: Copyright royalty judges have subpoena power over non-witnesses (Copyright Litigation Blog) International law: Wrestling the dead hand of history – Panel on Nazi looted art (Copyright Litigation Blog)   US Copyright – Decisions District Court E D Pennsylvania: $20 million copyright infringement jury award upheld in case concerning filched sales materials later used to poach clients: Graham v Haughey… [read post]
24 Apr 2009, 10:00 am
Two different views (Hal Wegner)   Spain Motion to amend penal code on IP rights (International Law Office)   Morocco Morocco signs up for Trademark Law Treaty (Afro-IP)   Poland District Administrative Court in Warsaw rules ‘heritage’ has no distinctive character in dispute between Zygmunt Piotrowski and Heritage Films (Class 46) Some simplified seizures stats for 2008 (Class 46)   South Africa High Court order restrains Eastwood(s) Tavern… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
12 Sep 2008, 2:33 pm
The case of Arabic language: (Intellectual Property Watch), Facebook – Is it commercially more than a bunch of pretty faces? [read post]
10 Jul 2010, 10:41 am by Peter Rost
By Martha Rosenberg, AlterNet Posted on July 10, 2010 The drug company Pfizer is best known for Lipitor, a drug that brings cholesterol down and Viagra, a drug that brings other things up.But the "world's largest research-based pharmaceutical company" which sits between Goldman Sachs and Marathon Oil on the Fortune 500, is also closely associated with a seemingly never-ending series of scandals.To say Pfizer's been accused of wrongdoing is like saying BP had an oil spill. [read post]
1 Oct 2018, 9:00 am by Michael H Cohen
  In the latter case, we can look to FDA warning letters as one primary resource to see whether FDA has flagged specific claims. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]